Lv41
510 积分 2024-09-04 加入
Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
3小时前
已完结
Effects of active vitamin D analogs and calcimimetic agents on PTH and bone mineral biomarkers in hemodialysis patients with SHPT: a network meta-analysis
3小时前
已完结
长期血液透析患者继发性甲状旁腺功能亢进症的流行病学分析
2个月前
已完结
Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism
3个月前
已完结
Critical Cysteine Residues in Both the Calcium-Sensing Receptor and the Allosteric Activator AMG 416 Underlie the Mechanism of Action
3个月前
已完结
Pharmacology of AMG 416 (Velcalcetide), a novel peptide agonist of the calcium-sensing receptor, for the treatment of secondary hyperparathyroidism in hemodialysis patients
3个月前
已完结
Etelcalcetide: First Global Approval
3个月前
已完结
糖尿病相关消化道症状的发病机制和临床诊疗进展
4个月前
已完结
Calcimimetic use in US hemodialysis facilities in first 2 years after the launch of etelcalcetide: A descriptive analysis of real-world clinical practice and outcomes
4个月前
已完结
Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis Patients
4个月前
已完结
皖公网安备34019202002308
